WGRX
Wellgistics Health, Inc.
Next earnings Aug 10, 2026
Last earnings +102.4% on 2026-05-19
$3.05
▲ +6.64%$3.05▼ -93.96%
over 1Y
L $2.82EODHDH $86.50
Earnings Dividend Split Congress buy Congress sellGrouped by date · hover a pin to expand
Today+6.6%
1W+6.6%
1M-3.5%
3M-39.6%
YTD-85.9%
1Y-94.0%
Avoid
Conviction
Horizon
Medium (3–12mo)
Revenue grew 28.7% YoY; but unprofitable (net margin -433.9%).
Revenue (FY2025) $23.3M · FY2025
Wellgistics Health, Inc. shows $23.3M in FY2025 revenue (+28.7% YoY), a -433.9% net margin.
Financials · annual, by fiscal year
| Line item | FY23 | FY24 | FY25 |
|---|---|---|---|
| Revenue | — | $18.1M | $23.3M |
| Gross profit | — | $1.77M | -$6.43M |
| Operating income | -$2.88M | -$6.15M | -$93.7M |
| Net income | -$2.90M | -$6.86M | -$101M |
| Diluted EPS | -$0.06 | -$0.15 | -$1.43 |
| Net margin | — | -37.8% | -433.9% |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Key statistics
Valuation
Enterprise value$343M
EV / EBITDA—
EV / Sales14.7
EV / FCF—
P / FCF—
PEG (trailing)—
Earnings yield-31.7%
FCF yield—
Quality & risk
ROIC (est.)—
Free cash flow—
Total debt$23.5M
Net cash-$23.4M
Altman Z-Score-11.08 distress
Piotroski F-Score2/9
Capital returns
Buyback yield—
Dividend yield (est.)—
Shareholder yield—
Shares Δ YoY+101.9%
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Disclosure timeline
SEC · 8-Ks + reportsRed flag in recent filings — delisting notice (2026-06-12). Worth a closer look.
Recent filings
all on EDGAR ↗4Period ending 2026-06-222026-06-25open ↗4Period ending 2026-06-222026-06-25open ↗4/APeriod ending 2026-03-312026-06-25open ↗4/APeriod ending 2026-03-312026-06-25open ↗PRE 14APeriod ending 2026-06-182026-06-18open ↗8-KPeriod ending 2026-06-092026-06-12open ↗8-K/APeriod ending 2026-05-272026-06-03open ↗8-K/APeriod ending 2026-05-272026-06-02open ↗8-KPeriod ending 2026-05-272026-05-29open ↗8-KPeriod ending 2026-05-212026-05-21open ↗8-KPeriod ending 2026-05-192026-05-21open ↗8-KPeriod ending 2026-05-192026-05-19open ↗
Frequently asked
- Is Wellgistics Health, Inc. (WGRX) a buy?
- WGRX currently carries a Avoid rating with 2/5 conviction, derived from its latest SEC filings. Revenue grew 28.7% YoY; but unprofitable (net margin -433.9%).
- What is Wellgistics Health, Inc.'s quality score?
- WGRX scores 31.41176470588235/100 (grade F) on a SEC-grounded quality model spanning value, growth, profitability, financial health and momentum.
Sources: SEC EDGAR (CIK 0002030763, latest 10-Q filed 2026-05-19) · EODHD · as of 6/26/2026, 3:57:53 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.